These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
438 related articles for article (PubMed ID: 19306098)
21. Active immunization trial in Abeta42-injected P301L tau transgenic mice. Kulic L; Kurosinski P; Chen F; Tracy J; Mohajeri MH; Li H; Nitsch RM; Götz J Neurobiol Dis; 2006 Apr; 22(1):50-6. PubMed ID: 16289870 [TBL] [Abstract][Full Text] [Related]
22. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology. Wang YJ; Chen GH; Hu XY; Lu YP; Zhou JN; Liu RY Brain Res; 2005 Jan; 1031(1):101-8. PubMed ID: 15621017 [TBL] [Abstract][Full Text] [Related]
23. [Brain lesions, pathogenic and etiologic hypotheses of Alzheimer's disease]. Dessi F; Colle MA; Hauw JJ; Duyckaerts C Rev Prat; 1998 Nov; 48(17):1873-8. PubMed ID: 9854388 [TBL] [Abstract][Full Text] [Related]
24. Wnt signaling in Alzheimer's disease: up or down, that is the question. Boonen RA; van Tijn P; Zivkovic D Ageing Res Rev; 2009 Apr; 8(2):71-82. PubMed ID: 19101658 [TBL] [Abstract][Full Text] [Related]
25. Differences in regional brain atrophy in genetic forms of Alzheimer's disease. Gregory GC; Macdonald V; Schofield PR; Kril JJ; Halliday GM Neurobiol Aging; 2006 Mar; 27(3):387-93. PubMed ID: 15894410 [TBL] [Abstract][Full Text] [Related]
26. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics. Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011 [TBL] [Abstract][Full Text] [Related]
27. [Neurofibrillary tangles and early modification of the neuronal cytoskeleton in Alzheimer's disease and in experimental models]. Brion JP Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):287-94. PubMed ID: 10992876 [TBL] [Abstract][Full Text] [Related]
28. Cerebral amyloid angiopathy: pathogenetic mechanisms and link to dense amyloid plaques. Kumar-Singh S Genes Brain Behav; 2008 Feb; 7 Suppl 1():67-82. PubMed ID: 18184371 [TBL] [Abstract][Full Text] [Related]
31. Modulation of tau pathology in tau transgenic models. Brion JP; Ando K; Heraud C; Leroy K Biochem Soc Trans; 2010 Aug; 38(4):996-1000. PubMed ID: 20658992 [TBL] [Abstract][Full Text] [Related]
32. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress. Lee KW; Kim JB; Seo JS; Kim TK; Im JY; Baek IS; Kim KS; Lee JK; Han PL J Neurochem; 2009 Jan; 108(1):165-75. PubMed ID: 19012747 [TBL] [Abstract][Full Text] [Related]
33. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models. Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827 [TBL] [Abstract][Full Text] [Related]
34. Aberrant accentuation of neurofibrillary degeneration in the hippocampus of Alzheimer's disease with amyloid precursor protein 717 and presenilin-1 gene mutations. Sudo S; Shiozawa M; Cairns NJ; Wada Y J Neurol Sci; 2005 Jul; 234(1-2):55-65. PubMed ID: 15946688 [TBL] [Abstract][Full Text] [Related]
35. Metabolic/signal transduction hypothesis of Alzheimer's disease and other tauopathies. Iqbal K; Grundke-Iqbal I Acta Neuropathol; 2005 Jan; 109(1):25-31. PubMed ID: 15645264 [TBL] [Abstract][Full Text] [Related]
36. The possible role of capillary cerebral amyloid angiopathy in Alzheimer lesion development: a regional comparison. Jeynes B; Provias J Acta Neuropathol; 2006 Oct; 112(4):417-27. PubMed ID: 16830133 [TBL] [Abstract][Full Text] [Related]
37. Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40. Kumar-Singh S; Theuns J; Van Broeck B; Pirici D; Vennekens K; Corsmit E; Cruts M; Dermaut B; Wang R; Van Broeckhoven C Hum Mutat; 2006 Jul; 27(7):686-95. PubMed ID: 16752394 [TBL] [Abstract][Full Text] [Related]
38. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758 [TBL] [Abstract][Full Text] [Related]